Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies

OBJECTIVE: To evaluate the clinical performance of non‐invasive prenatal testing for trisomy 21, 18, and 13 using targeted cell‐free DNA (cfDNA) analysis. METHODS: Targeted cfDNA analysis using DANSR™ and FORTE™ with microarray quantitation was used to evaluate the risk of trisomy 21, 18, and 13 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokowski, Renee, Wang, Eric, White, Karen, Batey, Annette, Jacobsson, Bo., Brar, Herb, Balanarasimha, Madhumitha, Hollemon, Desiree, Sparks, Andrew, Nicolaides, Kypros, Musci, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057317/
https://www.ncbi.nlm.nih.gov/pubmed/26332378
http://dx.doi.org/10.1002/pd.4686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057317/
https://www.ncbi.nlm.nih.gov/pubmed/26332378
http://dx.doi.org/10.1002/pd.4686

Ejemplares similares